Addressing Female Pattern Hair Loss with Mason Clinic's Scalp Protocols

Addressing Female Pattern Hair Loss with Mason Clinic's Scalp Protocols

Medically reviewed by Dr. Hyunju Kim, Medical Director, Mason Clinic

Noticing more hair in the brush, a widening part, or a thinner ponytail can be unsettling. Female pattern hair loss is common, it is a genuine medical condition, and it is often treatable, but the path forward depends on an accurate diagnosis first. This guide explains what female pattern hair loss (FPHL) is, which treatments have US Food and Drug Administration (FDA) authorization, and how the scalp protocols offered at Mason Clinic in Seoul fit into that picture from a US regulatory standpoint.

This article is educational. It is not a self-diagnosis tool, and it does not replace an evaluation by a qualified physician. Hair loss has many causes, and only an in-person assessment can determine what is happening with your hair and what may help.

What Female Pattern Hair Loss Is

Female pattern hair loss, also called female androgenetic alopecia, is the most common form of hair loss in women. It typically shows up as gradual thinning over the top and crown of the scalp and a widening of the central part, while the frontal hairline is often preserved. Unlike the receding hairline pattern more familiar in men, women more often experience a diffuse reduction in hair density.

FPHL involves a process in which affected hair follicles gradually produce finer, shorter hairs and spend less time in the active growth phase. Genetics and hormonal factors both play a role, which is why the condition is described as androgenetic. It can begin at various ages and may become more noticeable around hormonal transitions such as menopause.

The most important point is this: FPHL is a medical condition, not simply a cosmetic concern, and it should be evaluated by a physician. Many other conditions can cause or worsen hair thinning in women, including thyroid disorders, iron deficiency and other nutritional issues, certain medications, stress-related shedding (telogen effluvium), and autoimmune conditions such as alopecia areata. Some of these are reversible when the underlying cause is identified and addressed. Treating hair loss without first ruling out these causes can waste time and money and may miss a treatable medical issue. This is why a proper diagnosis comes first.

The FDA-Approved Medication for FPHL

When it comes to US-authorized treatment specifically for female pattern hair loss, the picture is precise, and it is worth stating plainly:

Topical minoxidil is the only FDA-approved medication for female pattern hair loss. Applied to the scalp, it is the medication that carries FDA approval for this specific use in women. As with any treatment, it does not work for everyone, results vary, it generally needs to be continued to maintain any benefit, and it is used under the guidance of a physician who can confirm it is appropriate for you.

A few related points help avoid common confusion:

Finasteride is not FDA-approved for women. Finasteride is an oral medication approved for male pattern hair loss. Its use in women is off-label, and it is contraindicated in pregnancy and in women who may become pregnant because of the risk of harm to a developing fetus. Any consideration of it in women is a medical decision that belongs strictly with a physician.

Low-level laser therapy (LLLT) devices are FDA-cleared as adjuncts. Certain LLLT devices for the scalp are FDA-cleared and are used as adjunctive (supportive) treatments rather than as stand-alone cures. FDA clearance for a device and FDA approval for a medication are different regulatory pathways, but both represent US authorization.

Understanding this baseline matters, because it gives you a clear reference point for evaluating any other treatment you may be offered, in the US or abroad.

How Regulatory Status Differs by Country

A treatment offered legally and routinely in South Korea has not necessarily been reviewed or authorized by the US FDA. Korea's regulator (MFDS) and the US FDA are separate systems with separate standards. This is central to understanding Mason Clinic's scalp protocols: they are offered in Seoul, but that is not the same as US FDA approval. Being clear about this lets you ask better questions and weigh your options honestly.

Mason Clinic's Scalp Protocols — and Their US Status

Mason Clinic offers a Hair and Scalp Therapy program that begins with a detailed scalp assessment, after which the clinic's medical director selects one or more treatment modalities based on the individual's condition. The clinic describes its process as a diagnostic-first approach that includes discussion of hair concerns and medical history, a scalp examination, hair loss pattern analysis, evaluation of follicular health, and assessment for inflammatory or immune-related conditions before an individualized plan is created. The stated goals include improving scalp health, supporting the follicular environment, enhancing scalp circulation, reducing scalp tension and inflammation, and supporting hair density and quality, with the clear caveat that individual results vary.

The specific modalities the clinic describes offering include the following. It is important to state plainly that these scalp protocols are not approved by the US FDA.

M Cell Hair Conditioning (stem cell-based). Mason Clinic describes this as a stem-cell-based regenerative therapy for the scalp. From a US standpoint, the FDA has not approved stem-cell therapies for aesthetic or hair-restoration use, and the FDA has issued a consumer alert about regenerative medicine products, including stem cells, cautioning that many such products are not FDA-approved and that their safety and effectiveness for these uses have not been established.

ASCE+ HRLV (exosome and growth factor therapy). Mason Clinic describes ASCE+ HRLV as an injection-based treatment using a regenerative exosome and growth factor formula delivered directly into the scalp to support follicle health and the natural hair growth cycle. Here the US position is unambiguous: no exosome product is FDA-approved for any use in the United States. The FDA has issued a public safety notification about exosome products and has warned about unapproved products in this category. Being listed with the FDA is not the same as being approved.

Hair Follicle Botox (off-label). Mason Clinic lists a Hair Follicle Botox injection among its scalp options. Botulinum toxin is not FDA-approved for hair or scalp treatment, so this represents an off-label use of the product.

None of this means women do not choose these treatments in Seoul, or that the clinic does not deliver them under physician supervision with its stated safeguards. It means that if you are coming from the US, you would be receiving treatments that your home regulator has not authorized for hair loss, that the described benefits are the clinic's positioning rather than FDA-established outcomes, and that results vary and cannot be guaranteed. No treatment described here promises hair regrowth. These are exactly the points to raise directly with the clinic and to weigh with your own physician.

Why an Accurate Diagnosis Comes First

For women's hair thinning, whether you are considering options in Seoul, in Korea more broadly, or at home, the single most valuable step is an accurate diagnosis. Because so many conditions can mimic or contribute to FPHL, a physician evaluation is needed to rule out other causes such as thyroid problems, iron deficiency, medication effects, stress-related shedding, and autoimmune causes. Identifying an underlying, treatable cause can change the entire plan and, in some cases, resolve the shedding without cosmetic procedures at all.

Mason Clinic's stated model reflects this diagnostic-first principle: a comprehensive scalp assessment and hair loss pattern analysis before any treatment is selected. Even so, a scalp assessment at an aesthetics clinic does not replace a broader medical work-up with your own physician, who can order appropriate tests and review your overall health, medications, and history. The two are complementary, and for hormonal hair thinning in particular, coordinating with a physician who knows your health picture is prudent.

Setting Realistic Expectations and Understanding Risks

Realistic expectations protect you from disappointment and from overtreatment. Hair growth is slow, and any treatment that influences the growth cycle takes time; the clinic notes that regenerative treatments such as M Cell Hair Conditioning and ASCE+ HRLV develop progressively as the scalp's biological processes occur over the following weeks and months. Even the FDA-approved medication, topical minoxidil, does not work for everyone and generally must be continued to maintain any benefit.

Outcomes vary from person to person, and no ethical clinic can promise regrowth or guarantee a result. Every procedure carries potential risks and side effects, which differ by treatment and by individual and should be discussed candidly during a consultation. Because the regenerative options in particular are not FDA-authorized, the FDA has specifically cautioned consumers about safety concerns associated with unapproved products in this category. A responsible consultation covers what a treatment can and cannot do, the aftercare involved, and the honest limits of the evidence.

If you are considering traveling to Seoul, practical matters such as booking, payment, travel timing, interpretation, and follow-up once you return home should be confirmed directly with the clinic. Continuity of care with your physician at home is part of responsible planning, especially for a condition that is managed over time rather than cured in a single visit.

How Mason Clinic Approaches Women's Hair Loss

Mason Clinic frames Mason Clinic women's hair loss care around individualized, physician-supervised treatment. The clinic describes a consultation that includes discussion of concerns and medical history, scalp examination, hair loss pattern analysis, follicular health evaluation, and assessment for inflammatory or immune-related conditions, followed by an individualized plan that may combine one or more of its modalities. Supportive elements the clinic describes include authenticated products, documented dosing, private in-room treatment, personalized aftercare, follow-up consultations, progress monitoring, and long-term maintenance planning. An English-speaking team and online consultations are described as available.

For non-surgical hair restoration seekers and for those researching ASCE+ HRLV for women or M Cell hair loss women treatments, this assessment-driven structure is worth understanding, but it does not change the regulatory status of the individual treatments. The clinic's protocols remain not FDA-approved regardless of how carefully they are personalized, which is why the honest framing throughout this guide is that they are options offered in Seoul, to be weighed alongside the FDA-approved baseline and with your own physician's input.

Bottom Line

Female pattern hair loss is a common, genuine medical condition that deserves an accurate diagnosis before treatment, because many other conditions can cause similar thinning and some are reversible. From a US regulatory standpoint the reference points are clear: topical minoxidil is the only FDA-approved medication for FPHL, finasteride is not FDA-approved for women (off-label and contraindicated in pregnancy), and certain low-level laser therapy devices are FDA-cleared as adjuncts. Mason Clinic's scalp protocols, including M Cell Hair Conditioning (stem cell-based), ASCE+ HRLV (exosome and growth factor therapy), and Hair Follicle Botox (off-label), are offered in Seoul but are not FDA-approved. Results vary and cannot be guaranteed, and no responsible treatment promises regrowth. Start with a physician evaluation to rule out other causes, understand your options honestly, and make decisions with qualified medical guidance.

Frequently Asked Questions

**What is female pattern hair loss?**Female pattern hair loss, or female androgenetic alopecia, is the most common form of hair loss in women. It usually appears as gradual thinning over the top and crown and a widening central part, often sparing the frontal hairline. It is a medical condition influenced by genetic and hormonal factors and should be evaluated by a physician.

**Which hair loss treatment is FDA-approved for women?**Topical minoxidil is the only FDA-approved medication for female pattern hair loss. Finasteride is not FDA-approved for women; its use in women is off-label and it is contraindicated in pregnancy. Certain low-level laser therapy devices are FDA-cleared as adjuncts. These decisions should be made with a physician.

**Are Mason Clinic's scalp protocols FDA-approved?**No. M Cell Hair Conditioning (stem cell-based), ASCE+ HRLV (exosome and growth factor therapy), and Hair Follicle Botox (off-label) are not approved by the US FDA. The FDA has not approved stem-cell therapies for such use, no exosome product is FDA-approved, and botulinum toxin is not FDA-approved for the scalp. They are offered in Seoul, where regulatory systems differ from the US.

**Why do I need to see a physician before treating hair loss?**Because many conditions can cause hair thinning in women, including thyroid disorders, iron deficiency, medication effects, stress-related shedding, and autoimmune conditions such as alopecia areata. Some are reversible once identified. A physician can order appropriate tests and rule out other causes before you pursue any treatment.

**Will these treatments regrow my hair?**No treatment described here promises hair regrowth. Hair responds slowly, results vary from person to person, and outcomes cannot be guaranteed. Even the FDA-approved medication does not work for everyone and generally must be continued to maintain any benefit. Every procedure also carries potential risks to discuss in a consultation.

**Can I coordinate care between Mason Clinic and my own physician?**Yes, and it is advisable. A scalp assessment at an aesthetics clinic does not replace a broader medical work-up. Consult your own physician to review your overall health, medications, and history, and confirm any travel, aftercare, and follow-up logistics directly with the clinic.

Disclaimer

This article is for general educational purposes only and is not a self-diagnosis tool or a substitute for professional medical advice. It does not establish a physician-patient relationship. Female pattern hair loss and other causes of hair thinning should be evaluated by a qualified physician, who can rule out underlying conditions. Candidacy for any treatment requires an in-person consultation. Regulatory status, safety information, and availability of treatments differ by country; treatments described as offered in Seoul may not be authorized by the US FDA. Individual results vary, cannot be guaranteed, and all procedures carry potential risks and side effects. Please consult a qualified physician or dermatologist, and contact Mason Clinic directly to confirm details, logistics, and suitability.